Global (AMER, APAC, BRICS and EMEA) Helicobacter Pylori Diagnostics Market Size, Status and Forecast 2019-2025 (Includes Business Impact of COVID-19)

  • TBI87299
  • November 28, 2020
  • Global
  • 134 pages
  • TSCIR
                                          

Abstract, Snapshot, Market Analysis & Market Definition: Helicobacter Pylori Diagnostics Market

Helicobacter pylori (H. pylori) is a Gram-negative, microaerobic human pathogen and H. pylori infection is strongly related with many gastroduodenal diseases including chronic active gastritis, peptic ulcer diseases, atrophic gastritis, mucosa associated lymphoid tissue (MALT) lymphoma and noncardia gastric cancer. H. pylori infection affects more than half of the adult population worldwide, but the prevalence of H pylori infection varies widely by geographic area, age, race, and socioeconomic status. Usually, the prevalence of H. pylori increases with age in most countries, however a decline in prevalence of H. pylori infection has been observed in recent decades in time trend analysis of several large populations. More than 80% of peptic ulcer diseases are caused by H. pylori infection and the estimated lifetime risk for peptic ulcer disease in H. pylori-infected patients is approximately 15%. Gastric cancer is the third leading cause of cancer-related death worldwide and H. pylori infection is responsible for 74.7% of all noncardia gastric cancer cases. Gastric cancer and peptic ulcer together cause more than a million deaths per year in the world and H. pylori infection always is an important health issue. Various diagnostic methods are developed to detect H. pylori infection and diagnostic tests with both high sensitivity and specificity, exceeding 90%, are necessary for accurate diagnosis of H. pylori infection in clinical practice. Although many diagnostic tests are available now, each method has its own advantages, disadvantages, and limitations. The choice of one method or another could be depended on availability and accessibility of diagnostic tests, level of laboratories, clinical conditions of patients, and likelihood ratio of positive and negative tests on different clinical circumstances. Diagnostic tests are usually divided into invasive (endoscopic-based) and noninvasive methods. Invasive diagnostic tests include endoscopic image, histology, rapid urease test, culture, and molecular methods. Non-invasive diagnostic tests included Non-invasive Techniques, stool antigen test, serological, and molecular examinations. One of the key drivers witnessed in the market is the growing cost-effectiveness of diagnosis and personalized antibiotic therapy. H. pylori bacteria causes ulcer. H. pylori infection requires antibiotic therapy that includes 10-14 days treatment regimen. This treatment regimen comprises of one or two antibiotics such as amoxicillin, tetracycline, metronidazole, or clarithromycin in combination with ranitidine bismuth citrate, bismuth subsalicylate, and a proton pump inhibitor (PPI). Ulcer-related symptoms such as abdominal pain and nausea and inflammation of gastric mucosa can be cured using PPIs or H2 blockers in combination with antibiotics. The cost-effectiveness of antibiotics and the lesser duration of treatment boosts the adoption of antibiotic regimen by healthcare professionals. This in turn, will drive the demand for pre- and post-monitoring tests. In terms of geography, the Europe accounted for the majority market shares during 2017 and this mainly accounted to the growing prevalence of peptic ulcer disease and gastritis. The increasing patient pool looking for the early detection of symptoms and treatment is boosting the demand for helicobacter pylori diagnostics in the region. Owing to the continuous efforts of vendors to develop a vaccination for H. pylori infection and the introduction of improved diagnostic techniques, the market will continue to witness considerable growth in this region during the next four years as well. The helicobacter pylori diagnostics market is characterized by the presence of major vendors and is highly competitive. These vendors compete against each other based on factors including pricing, product differentiation, and advancements in technology. Vendors are highly focusing on expanding their product portfolio and increasing investments in acquiring other players, which will help them increase their revenue shares. Additionally, they are also focusing on the development of vaccines and enhancing their presence in the regional and untapped markets. Hospitals and clinics reduce the overall disease burden and promote health by offering immunoassays and molecular diagnostic techniques. These techniques enable the early diagnosis of infectious and lethal diseases. The patient pool suffering from infectious diseases such as bacterial diseases (enteric bacteria), cancer, and other life-threatening diseases highly rely on hospitals since they have tie-ups with research and developmental centers and research institutes. In 2018, the global Helicobacter Pylori Diagnostics market size was 511.5 million US$ and it is expected to reach 838.8 million US$ by the end of 2025, with a CAGR of 7.3% during 2019-2025. This report focuses on the global Helicobacter Pylori Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Helicobacter Pylori Diagnostics development in United States, Europe and China.

Market Segmentation, Outlook & Regional Insights: Helicobacter Pylori Diagnostics Market

Segmentation by Product Type: Breakdown of data from year 2014 to 2019 and forecast until 2025:

  • Invasive Techniques
  • Non-invasive Techniques

Segmentation by Application: Breakdown of data from year 2014 to 2019 and forecast until 2025:

  • Hospitals and Clinics
  • Diagnostic Laboratories

Market segment by Regions/Countries, this report covers

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

Key Players, Recent Developments & Sector Viewpoints: Helicobacter Pylori Diagnostics Market

  • Sekisui Diagnostics
  • F. Hoffmann-La Roche
  • Medline Industries
  • Meridian Bioscience
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • Alpha Laboratories
  • EKF Diagnostics
  • Quidel
  • Halyard Health
  • Cardinal Health
  • Beckman Coulter
  • Agilent Technologies
  • Coris BioConcept

Key Insights Covered: Exhaustive Helicobacter Pylori Diagnostics Market

1. Market size (sales, revenue and growth rate) of Helicobacter Pylori Diagnostics industry. 2. Global major manufacturers operating situation (sales, revenue, growth rate and gross margin) of Helicobacter Pylori Diagnostics industry. 3. SWOT analysis, New Project Investment Feasibility Analysis, Upstream raw materials and manufacturing equipment & Industry chain analysis of Helicobacter Pylori Diagnostics industry. 4. Market size (sales, revenue) forecast by regions and countries from 2019 to 2025 of Helicobacter Pylori Diagnostics industry.

Research Methodology: Helicobacter Pylori Diagnostics Market

  • Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request a Sample Report.
  • Demand Side Primary Contributors: OEMs, Industrial Professionals, Researches, Suppliers and Distributors, Group Purchasing Organizations, Associations, Insurers, Universities, Technological Writers, Scientists, Promoters, Investors among others.
  • Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others.

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type

1.4.1 Global Helicobacter Pylori Diagnostics Market Size Growth Rate by Type (2014-2025)

1.4.2 Invasive Techniques

1.4.3 Non-invasive Techniques
1.5 Market by Application

1.5.1 Global Helicobacter Pylori Diagnostics Market Share by Application (2014-2025)

1.5.2 Hospitals and Clinics

1.5.3 Diagnostic Laboratories
1.6 Study Objectives
1.7 Years Considered2 Global Growth Trends
2.1 Helicobacter Pylori Diagnostics Market Size
2.2 Helicoba
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form